Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Phesgo 600mg/600mg


Contraindicated
Reproductive toxicity in animals

Contraindicated
Phesgo 600mg/600mg :
Type Medicine Authorised
Originator Biotech (Phesgo)
Agent Omnipharma
Distributor Omnipharma
Laboratory Roche
Responsible Party F. Hoffmann La Roche Ltd
Origin Switzerland
Manufacturer F. Hoffmann La Roche Ltd, Kaiseraugst
Origin Switzerland
ATC L01XY02

Your comment will appear shortly after approval

Phesgo 600mg/600mg :

Revision Date : 02/03/2022


Effect Frequency
Abdominal pain Very Common
Alopecia Very Common
Anaemia Very Common
Anaphylactic reactions Uncommon
Arthralgia (Pain joint) (Joint ache) Very Common
Asthenia Very Common
Chills Common
Congestive heart failure Uncommon
Constipation Very Common
Cough Very Common
Cytokine release syndrome Rare
Decreased appetite Very Common
Diarrhoea (Diarrhea) Very Common
Dizziness Very Common
Drug hypersensitivity Common
Dry skin Very Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Very Common
Dyspnoea (dyspnea) Very Common
Epistaxis (Nasal bleeding) Very Common
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Very Common
Headache Very Common
Hot flush Very Common
Hypersensitivity Common
Infusion related reaction Very Common
Injection site reaction Very Common
Insomnia Very Common
Interstitial lung disease Uncommon
Lacrimation increased (Epiphora) Very Common
Left ventricular dysfunction Common
Leucopenia (Leukopenia) Very Common
Mucosal inflammation Very Common
Myalgia Very Common
Nail disorders Very Common
Nasopharyngitis Very Common
Nausea Very Common
Neuropathy peripheral Very Common
Neutropenia Very Common
Oedema Common
Oedema peripheral Very Common
Pain Common
Pain in extremity (Pain in limb) Very Common
Paraesthesia (paresthesia) Very Common
Paronychia Common
Peripheral sensory neuropathy Very Common
Pleural effusion Uncommon
Pruritus Very Common
Pyrexia Very Common
Skin rash Very Common
Stomatitis Very Common
Tumour lysis syndrome Rare
Upper respiratory tract infection Common
Vomiting Very Common

Different Units By MoH Code

Revision Date : no date

Revision Date : no date

Phesgo 600mg/600mg  MoH 11169 :
Form Solution for injection
Packaging Vial (Type I Glass)
Package Size 1x10ml
Strength 600mg/600mg
Storage Condition 2-8°C Protect from light. Do not freeze
Public Price 5348082 L.L.
Stratum E2
NSSF ✔
Quarantine ✘
Reg. Number 118621/1
Submission date 12/10/2021
Registration Year 01/02/2022


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x10ml
● Public Price: 5348082 LBP ( 5,348,082.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 5348082 LBP ( 5,348,082.00 LBP )
● Pricing Date: 13/06/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Early breast cancer : (Adults)
● Cost/Unit: 5348082 LBP ( 5,348,082.00 LBP )
● Cost/Day: 5348082 LBP ( 5,348,082.00 LBP )
● Cost/Month: 5348082 LBP ( 5,348,082.00 LBP )
Metastatic breast cancer : (Adults)
● Cost/Unit: 5348082 LBP ( 5,348,082.00 LBP )
● Cost/Day: 5348082 LBP ( 5,348,082.00 LBP )
● Cost/Month: 5348082 LBP ( 5,348,082.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info